Sientra Is Finally Recovering. Is It a Buy?
While the aesthetics market is growing at a substantial pace, not every company in this field has been doing well. Medical aesthetics product maker Sientra (NASDAQ: SIEN) has been on a downward trend over the past year, giving back around half of its market value during that time frame. However, shares of this $437 million healthcare stock shot up significantly last week when the company announced impressive third-quarter sales figures and boosted its year-end guidance.
While it's definitely a piece of much needed good news for Sientra, there are still a few areas of concern that investors should keep in mind before adding this stock to their portfolio. Below we'll look at Sientra's recent financial results as well as some pros and cons surrounding the company.
IMAGE SOURCE: GETTY IMAGES.
Source Fool.com
